Source: Virtual Congress 2021 – Biological and functional markers of COVID-19



Rating:

Share or cite this content

Citations should be made in the following way:
M. DOBRIN (IASI, Romania), O. Rohozeanu (IASI, Romania), R. Crisan-Dabija (IASI, Romania), R. Cernat (IASI, Romania), I. Buculei (IASI, Romania), R. Cernat (IASI, Romania), E. Popa (IASI, Romania), A. Trofor (IASI, Romania). Prospective biochemical and hematological markers to differentiation severe from non-severe COVID-19 disease. 3879

Member's Comments

No comment yet.

Related content which might interest you: Clinical, functional and radiologic progression in Interstitial pneumonia with autoimmune features (IPAF): a prospective cohort-study Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma Source: Eur Respir J 2003; 22: 470-477 Year: 2003 1-year prospective study in severe COPD patients: marker of inflammation, lung function and radiologic evaluation Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Inflammatory phenotypes of severe exacerbation of COPD, a clinico-laboratory characterization. Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021 Physiologic markers of small-airways disease and their clinical relevance Source: Annual Congress 2013 –Small airways in asthma: from physiologic measures to clinical relevance Year: 2013 Prospective evaluation of pulmonary vascular involvement in patients with chronic myeloproliferative disorders Source: Annual Congress 2007 - Pulmonary hypertension Year: 2007 Correlation of renal impairment with biochemical and radiological findings, and clinical outcome in COVID-19 pneumonia patients Source: Virtual Congress 2021 – COVID - 19 biomarkers Year: 2021 Hematologic, immunologic and other tests in the evaluation of lung disease Source: Annual Congress 2013 –PG17 Diagnostic tests for paediatric pulmonologists Year: 2013 Temporal profile and clinical utility of inflammatory markers in patients with acute exacerbation of COPD Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008 Structural and biochemical characteristics of subclinical atherosclerosis in COPD Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 Clinical and functional characteristics of patients with acute severe COPD with or without ischemic heart disease Source: Eur Respir J 2006; 28: Suppl. 50, 162s Year: 2006 Prospective study of lung function in children with sickle cell disease Source: Eur Respir J 2003; 22: Suppl. 45, 309s Year: 2003 Inflammatory markers of atherogenesis in patients with uncontrolled severe asthma Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases Year: 2017 Clinical features and outcomes of patients with myositis associated-interstitial lung disease Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Clinical characteristics of severe asthma subphenotypes Source: Annual Congress 2012 - Asthma: assessment and treatment Year: 2012 Hematological changes in COVID-19 and their association with the severity of the disease Source: Virtual Congress 2021 – Biological and functional markers of COVID-19 Year: 2021 Can extended hematological parameters of inflammation predict the severity and outcome of AECOPD? Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 Clinical features and outcome of patients with acute exacerbation of interstitial pneumonia associated with collagen vascular disease Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010 Interstitial pneumonia with autoimmune features associated with myositis autoantibodies: clinical characteristics from a multicenter Latin-American cohort. Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019 Role and distribution of infectious agents in exacerbations of moderate, severe and very severe forms of chronic obstructive lung disease: a prospective trial Source: Eur Respir J 2006; 28: Suppl. 50, 735s Year: 2006